Filter
3321
Filtered Results: 3321
Text search:
WHO
drug
use
indicators
Featured
Recommendations
280
New Publications
1010
Language
Document type
No document type
2099
Studies & Reports
519
Guidelines
345
Manuals
139
Strategic & Response Plan
136
Training Material
33
Fact sheets
25
Situation Updates
16
Infographics
7
Brochures
1
Online Courses
1
Countries / Regions
India
199
Kenya
116
Global
113
Uganda
93
Ethiopia
93
Nepal
81
Tanzania
79
Nigeria
76
Malawi
75
Western and Central Europe
69
South Africa
67
Zambia
66
Sierra Leone
63
Liberia
60
Ghana
59
Latin America and the Carribbean
55
Bangladesh
55
Myanmar / Burma
52
Namibia
48
Rwanda
46
Africa
40
Ukraine
33
Zimbabwe
33
Eastern Europe
33
Philippines
31
Lesotho
29
Cambodia
29
South–East Asia Region
29
Asia
25
Indonesia
21
Botswana
20
Congo, Democratic Republic of
17
Senegal
15
Burkina Faso
15
Eswatini/ Swaziland
15
Mozambique
14
Cameroon
11
Haiti
11
Russia
11
Eastern Europe and Central Asia
10
East and Southern Africa
10
Pakistan
10
Colombia
9
Syria
9
Albania
9
Georgia
9
Venezuela
8
West and Central Africa
8
Brazil
8
Middle East and North Africa
7
Thailand
6
Moldova
6
South Sudan
6
Laos
5
Peru
5
Guinea
5
Germany
5
Lebanon
5
Vietnam
5
Sudan
5
North Macedonia
4
Tajikistan
4
Timor Leste/ East Timor
4
El Salvador
4
Benin
4
China
4
Armenia
4
USA
4
Western Pacific Region
4
North America
4
Argentina
4
Mexico
3
Chile
3
Afghanistan
3
Jordan
3
Bolivia
3
Papua New Guinea
3
Sri Lanka
3
Honduras
3
Bhutan
3
Iraq
3
Turkey
2
Kazakhstan
2
Iran
2
Estonia
2
Kyrgyzstan
2
Morocco
2
Mongolia
2
Saudi Arabia
2
Paraguay
2
Turkmenistan
2
France
2
United Kingdom
2
Portugal
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Nicaragua
2
Central African Republic
2
Mali
2
Guatemala
2
North Korea
1
Serbia
1
Gambia
1
Fiji
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Bulgaria
1
Italy
1
Dominican Republic
1
Hungary
1
Ireland
1
Gabon
1
Uruguay
1
Jamaica
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belarus
1
Belize
1
Costa Rica
1
Panama
1
Greece
1
Palestine
1
Poland
1
Libya
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1515
Clinical Guidelines
244
Public Health
171
Women & Child Health
110
Key Resources
108
Pharmacy & Technologies
42
Capacity Building
36
Toolboxes
HIV
389
TB
305
Mental Health
227
AMR
184
NTDs
112
COVID-19
83
Pharmacy
77
Caregiver
66
NCDs
62
Malaria
61
Rapid Response
57
Planetary Health
39
Disability
32
Global Health Education
32
Conflict
31
Refugee
27
Ebola & Marburg
25
Health Financing Toolbox
21
Polio
14
Natural Hazards
12
Cholera
11
Specific Hazards
9
Zika
7
Social Ethics
4
This Tailoring Antimicrobial Resistance Programmes (TAP) process assists Member States in initiating and undertaking projects to address the spread of antimicrobial resistance (AMR) in their countries. AMR is a complex problem requiring unique, context-specific solutions. This TAP Toolbo...
The "Assessing National Capacity for the Prevention and Control of Noncommunicable Diseases: Report of the 2021 Global Survey" by WHO examines the global state of readiness and infrastructure for managing noncommunicable diseases (NCDs) across countries. Based on the 2021 survey, it analyzes nationa...
The document introduces a simple classification, minimums standards and a registration form for Foreign Medical Teams (FMTs) that may provide surgical and trauma care arriving within the aftermath of a sudden onset disaster. These can serve as tools to improve the coordination of the foreign medical...
Interim guidance. 12 May 2021. The Continuity of essential health services: Facility Assessment Tool can be used by countries to rapidly assess the capacity of health facilities to maintain the provision of essential health services during the COVID-19 pandemic. It can help to alert the authorities ...
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The ...
The core of the strategy is the goal for all patients to have better overall care, so that the numbers of deaths and cases of disability are reduced by 50% before 2030. For this to be achieved, four strategic aims will be pursued.
Empower and engage communities,
Ensure safe, effective trea...
his practical Guide serves as a companion to the “WHO guideline: recommendations on digital interventions for health system strengthening” and provides a systematic process for countries to develop a costed implementation plan for digital health within one or more health programme areas, drawing...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
This document highlights the key aspects of safe health-care waste management in order to guide policy-makers, practitioners and facility managers to improve such services in health-care facilities. It is based on the comprehensive WHO handbook Safe management of wastes from health-care activities (...
Technical Brief
July 2017
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can...
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can...
The purpose of this document is to present and promote the minimum requirements for IPC programmes at the national and health care facility level, identified by expert consensus according to available evidence and in the context of the WHO core components.
The minimum requirements are defined as: I...
Q5: What is the added advantage of doing an electroencephalography (EEG) in people with convulsive epilepsy in non- specialist settings in low and middle income countries?
A Global Campaign Against Epilepsy Demonstration Project
Managing epidemics
recommended
Key facts about major deadly diseases.This manual provides concise and up-to-date knowledge on 15 infectious diseases that have the potential to become international threats, and tips on how to respond to each of them.
You can download an interactive version directly at the website
http://www.who....
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
